Mr. Simon pleaded guilty in January to soliciting kickbacks from AstraZeneca, telling a company representative in 2017 that his prescriptions for Movantik, a medicine for patients with opioid-induced constipation, would be contingent on the number of paid speaking engagements he gave on behalf of the company. If AstraZeneca provided him with additional speaking engagements, Mr. Simon said he would prescribe Movantik to more patients, according to his plea agreement.
AstraZeneca stopped giving Mr. Simon speaking engagements after the conversation with his representative and conducted an internal investigation.
Mr. Simon is no longer able to practice medicine in Kansas.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.